Is it acceptable to approach colorectal cancer patients at diagnosis to discuss genetic testing? A pilot study.
Is it acceptable to approach colorectal cancer patients at diagnosis to discuss genetic testing? A pilot study.
复制标题
在诊断中接近结直肠癌患者讨论基因检测是可以接受的吗？试点研究。
DOI：
10.1038/sj.bjc.6601332
复制
发表时间：
2003-10-20
影响因子：
8.8
通讯作者：
Cull, A
中科院分区：
文献类型：
--
作者：
Porteous, M;Dunckley, M;Appleton, S;Catt, S;Dunlop, M;Campbell, H;Cull, A
在这项试点研究中，对近 111 名新诊断的结直肠癌患者接受遗传性非息肉病性结直肠癌 (HNPCC) 基因检测的接受程度进行了评估。共有 78% 的参与者表示非常愿意当时关注 HNPCC 的信息。
In this pilot study, the acceptability of approaching 111 newly diagnosed colorectal cancer patients with the offer of genetic testing for hereditary nonpolyposis colorectal cancer (HNPCC) was assessed. A total of 78% of participants found it highly acceptable to have the information about HNPCC brought to their attention at that time.